Trial · NCT04018612
Results by group248
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 248
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Sum of Pain Intensity Difference From 0 to 24 Hours (SPID24) Based on the 11 Point Numeric Pain Rating Scale | High Dose APAP | -96.80 | Standard Error 6.369 | score on a scale | |
| Sum of Pain Intensity Difference From 0 to 24 Hours (SPID24) Based on the 11 Point Numeric Pain Rating Scale | Low Dose APAP | -100.69 | Standard Error 6.333 | score on a scale | |
| Sum of Pain Intensity Difference From 0 to 24 Hours (SPID24) Based on the 11 Point Numeric Pain Rating Scale | Placebo | -74.96 | Standard Error 9.055 | score on a scale | |
| Sum of Pain Relief From 0 to 24 Hours (TOTPAR24) Based on a 5-point Likert Scale. | High Dose APAP | 55.82 | Standard Error 3.024 | score on a scale | |
| Sum of Pain Relief From 0 to 24 Hours (TOTPAR24) Based on a 5-point Likert Scale. | Low Dose APAP | 55.24 | Standard Error 3.007 | score on a scale | |
| Sum of Pain Relief From 0 to 24 Hours (TOTPAR24) Based on a 5-point Likert Scale. | Placebo | 43.11 | Standard Error 4.300 | score on a scale | |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | High Dose APAP | Median time to FPR-C (hours)- for moderate baseline categorical pain intensity score | 0.215 | Full Range 0.080 to 1.000 | hours |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Low Dose APAP | Median time to FPR-C (hours)- for moderate baseline categorical pain intensity score | 0.160 | Full Range 0.030 to 0.430 | hours |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Placebo | Median time to FPR-C (hours)- for moderate baseline categorical pain intensity score | 0.595 | Full Range 0.060 to 24.00 | hours |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | High Dose APAP | Median time to FPR-C (hours)- for severe baseline categorical pain intensity score | 0.160 | Full Range 0.030 to 24.00 | hours |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Low Dose APAP | Median time to FPR-C (hours)- for severe baseline categorical pain intensity score | 0.220 | Full Range 0.060 to 24.00 | hours |
| Time to Perceptible Pain Relief Confirmed (FPR-C) After Dose 1 Administration Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Placebo | Median time to FPR-C (hours)- for severe baseline categorical pain intensity score | 0.890 | Full Range 0.040 to 24.00 | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | High Dose APAP | Median time to MPR (hours)- for moderate baseline categorical pain intensity score | 0.660 | Full Range 0.250 to 24.00 | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Low Dose APAP | Median time to MPR (hours)- for moderate baseline categorical pain intensity score | 0.310 | Full Range 0.110 to 24.00 | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Placebo | Median time to MPR (hours)- for moderate baseline categorical pain intensity score | NA | Full Range NA to NA | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | High Dose APAP | Median time to MPR (hours)- for severe baseline categorical pain intensity score | 0.680 | Full Range 0.120 to 24.00 | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Low Dose APAP | Median time to MPR (hours)- for severe baseline categorical pain intensity score | 0.870 | Full Range 0.150 to 24.00 | hours |
| Time to Meaningful Perceptible Relief (MPR) Measure Stratified by Baseline Pain Score of Moderate or Severe for the 3 Treatment Groups | Placebo | Median time to MPR (hours)- for severe baseline categorical pain intensity score | NA | Full Range NA to NA | hours |
| Patient Global Evaluation of the Study Medication | High Dose APAP | 2.8 | Standard Error 0.16 | score on a scale | |
| Patient Global Evaluation of the Study Medication | Low Dose APAP | 2.7 | Standard Error 0.15 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04018612/results